Massachusetts Institute of Technology

"Living drug factories" may one day replace injections

Patients with diabetes generally rely on constant injections of insulin to control their disease. But MIT spinout Sigilon Therapeutics is developing an implantable, insulin-producing device that may one day make injections ...

May 17, 2018
popularity12 comments 0

Virtual drug trials boost results

Bringing a new drug to market can cost more than two billion dollars. Not to mention years of work spent developing and testing for scientists, researchers, doctors, and trial participants. By bringing trials to the virtual ...

May 02, 2018
popularity4 comments 0